Male infertility associated with a unique 8;22 translocation

被引:6
作者
Mark, HFL [1 ]
Sigman, M
机构
[1] Rhode Isl Hosp, Lifespan Acad Med Ctr, Cytogenet Lab, Providence, RI 02902 USA
[2] Rhode Isl Hosp, Dept Urol, Providence, RI USA
[3] Brown Univ, Sch Med, Providence, RI 02912 USA
关键词
cytogenetics; GTG-banding; fluorescent in situ hybridization; FISH; male infertility; semen analysis;
D O I
10.1006/exmp.1999.2257
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Proper evaluation of male infertility includes a careful history, physical examination, semen analysis, and karyotyping. Molecular cytogenetic analysis may also be necessary to further delineate the karyotype. Following the above approach, we found an apparently unique 8;22 translocation in a male patient with infertility but few other phenotypic manifestations. Delineating the exact genetic basis of infertility is important in view of the most recent advances in reproductive technology such as in vitro fertilization and intracytoplasmic sperm injection. Patients utilizing these emerging techniques need to be properly counseled as to their risks of transmitting these chromosomal abnormalities to their offspring, (C) 1999 Academic Press.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 16 条
[1]  
MARK HFL, 1994, ANN CLIN LAB SCI, V24, P153
[2]   A multimodal approach in the diagnosis of patients with hematopoietic disorders [J].
Mark, HFL ;
Gray, Y ;
Mark, Y ;
Khorsand, J ;
Sikov, W .
CANCER GENETICS AND CYTOGENETICS, 1999, 109 (01) :14-20
[3]   CONSTITUTIONAL TRISOMY-8 MOSAICISM AND GESTATIONAL TROPHOBLASTIC DISEASE [J].
MARK, HFL ;
AHEARN, J ;
LATHROP, JC .
CANCER GENETICS AND CYTOGENETICS, 1995, 80 (02) :150-154
[4]  
MARK HFL, 1995, ANN CLIN LAB SCI, V25, P402
[5]  
Mark HFL, 1996, CLIN PEDIATR, V35, P62
[6]  
Mark HFL, 1996, CYTOBIOS, V87, P137
[7]  
Mark HFL, 1998, CANCER, V83, P839, DOI 10.1002/(SICI)1097-0142(19980901)83:5<839::AID-CNCR5>3.0.CO
[8]  
2-D
[9]   A NOVEL, CONVENIENT, AND INEXPENSIVE APPROACH FOR DERIVING ISCN (1985) RELATIVE LENGTHS - VALIDATION BY A MORPHOMETRIC STUDY OF 100 KARYOTYPED METAPHASE CELLS [J].
MARK, HFL ;
PARMENTER, M ;
CAMPBELL, W ;
MARK, R ;
ZOLNIERZ, K ;
DUNWOODIE, D ;
HANN, E ;
AIRALL, E ;
SANTORO, K ;
MARK, Y .
CYTOGENETICS AND CELL GENETICS, 1993, 62 (01) :13-18
[10]  
MARK HFL, 1997, CANCER GENET CYTOGEN, V100, P1